CHEST Guidelines-Diagnosis and Management of Lung Cancer Intro, 3rd edition

Diagnosis and Management of Lung Cancer Intro, 3rd edition

Pdf Summary

The third edition of the American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines addresses the diagnosis and management of lung cancer. The introduction highlights that lung cancer continues to be a leading cause of cancer death despite treatment advancements. In 2012, over 226,000 new cases were expected in the United States, with a significant number of deaths projected. The third edition follows the traditions of its predecessors in 2003 and 2007, emphasizing that while the disease remains prevalent, ongoing research offers reasons for optimism.<br /><br />This edition of the guidelines is developed with advanced rigor and methodological precision, using the ACCP grading system to classify recommendations based on their strength and evidence quality. Grades range from strong (Grade 1) to weak (Grade 2), and evidence quality is classified as high (Grade A), moderate (Grade B), or low (Grade C).<br /><br />Significant updates in the third edition include the incorporation of the 2009 TMN classification and staging system, new articles on the molecular biology of lung cancer, and treatment of tobacco dependence. The guidelines also emphasize palliative and end-of-life care, reflecting contemporary understanding of non-small cell lung cancer. The guidelines aim to synthesize literature findings with expert insights to support physicians in delivering optimal patient care.<br /><br />Acknowledgments are extended to the many contributors who devoted time and effort to this project, including Frank Detterbeck as Vice Chair and Rebecca Diekemper for her role in guiding the effort. The guidelines, developed with support from the ACCP and other organizations, serve as a resource for healthcare professionals but are not a substitute for clinical judgment.<br /><br />Overall, the guidelines underscore a commitment to integrating new scientific discoveries with established clinical practices to improve lung cancer patient outcomes.

Keywords

lung cancer

ACCP guidelines

diagnosis

treatment advancements

evidence-based

TMN classification

molecular biology

palliative care

clinical practice

patient outcomes